Michael Kaczmarczyk
Overview
Explore the profile of Michael Kaczmarczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaczmarczyk M, Deuter C, Deus H, Kallidou A, Merz C, Hellmann-Regen J, et al.
Transl Psychiatry
. 2024 Oct;
14(1):449.
PMID: 39448569
Altered fear conditioning and extinction learning are discussed as key etiological features in anxiety disorders. Women have an increased risk for anxiety disorders and fear conditioning has been shown to...
2.
Deuter C, Kaczmarczyk M, Hellmann-Regen J, Kuehl L, Wingenfeld K, Otte C
Prog Neuropsychopharmacol Biol Psychiatry
. 2023 Dec;
129:110905.
PMID: 38043634
The glucocorticoid cortisol is the end product of the hypothalamic-pituitary-adrenal (HPA) axis and crucial for the stress response in humans. Cortisol regulates numerous biological functions by binding to two different...
3.
Kaczmarczyk M, Batke M, Wingenfeld K, Deuter C, Otte C
J Psychopharmacol
. 2023 Nov;
37(11):1082-1090.
PMID: 37942551
Background: The mood stabilizer lithium has a narrow therapeutic index with a relevant risk of intoxication. We used real-world hospital data to identify causes, treatment courses, and outcomes of high...
4.
Deuter C, Smit J, Kaczmarczyk M, Wingenfeld K, Otte C, Kuehl L
Compr Psychoneuroendocrinol
. 2022 Jun;
8:100077.
PMID: 35757673
Adverse childhood experiences (ACE) are a major risk factor for major depressive disorder (MDD) in later life. Both conditions are characterized by dysregulations in the noradrenergic system related which again...
5.
Kaczmarczyk M, Wingenfeld K, Nowacki J, Chae W, Deuter C, Piber D, et al.
J Psychiatr Res
. 2022 Jun;
152:97-103.
PMID: 35717867
Background: Major depressive disorder (MDD) is associated with impairments in spatial learning and memory and with altered functioning of central mineralocorticoid receptors (MR) and glutamatergic N-methyl-D-aspartate receptors (NMDA-R). Both receptors...
6.
Nowacki J, Wingenfeld K, Kaczmarczyk M, Chae W, Salchow P, Deuter C, et al.
J Psychopharmacol
. 2021 Apr;
35(8):1017-1023.
PMID: 33908312
Background: Mineralocorticoid receptors (MR) are highly expressed in limbic brain areas and prefrontal cortex, which are closely related to selective attention to emotional stimuli and emotion recognition. Patients with major...
7.
Otte C, Chae W, Nowacki J, Kaczmarczyk M, Piber D, Roepke S, et al.
BMJ Open
. 2020 Dec;
10(12):e040119.
PMID: 33262189
Introduction: Major depressive disorder (MDD) and obesity are both common disorders associated with significant burden of disease worldwide. Importantly, MDD and obesity often co-occur, with each disorder increasing the risk...
8.
Kaczmarczyk M, Spitzer C, Wingenfeld K, Wiedemann K, Kuehl L, Schultebraucks K, et al.
Eur J Psychotraumatol
. 2020 Nov;
11(1):1837511.
PMID: 33244366
Adverse childhood experiences (ACE) are associated with an increased risk of major depressive disorder (MDD) and hypothalamic-pituitary-adrenal (HPA) axis dysregulation. Within the HPA axis, corticotropin-releasing hormone and vasopressin (AVP) synergistically...
9.
Nowacki J, Wingenfeld K, Kaczmarczyk M, Chae W, Abu-Tir I, Deuter C, et al.
Neuropsychopharmacology
. 2020 Jul;
45(13):2155-2161.
PMID: 32722659
Mineralocorticoid receptors (MR) are predominantly expressed in the hippocampus and prefrontal cortex. Both brain areas are associated with social cognition, which includes cognitive empathy (ability to understand others' emotions) and...
10.
Nowacki J, Wingenfeld K, Kaczmarczyk M, Chae W, Salchow P, Abu-Tir I, et al.
Transl Psychiatry
. 2020 Apr;
10(1):109.
PMID: 32313032
Major depressive disorder (MDD) is associated with altered mineralocorticoid receptor (MR) and glucocorticoid receptor function, and disturbed glutamatergic signaling. Both systems are closely intertwined and likely contribute not only to...